Switch to:
PowerShares Dynamic Biotech &Genome  (ARCA:PBE) Peter Lynch Fair Value: N/A (As of Today)

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. The growth rate we use is the average growth rate for earnings per share over the past 5 years. If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25. If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

PowerShares Dynamic Biotech &Genome Annual Data

 Peter Lynch Fair Value

PowerShares Dynamic Biotech &Genome Semi-Annual Data

 Peter Lynch Fair Value

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.

Calculation

PowerShares Dynamic Biotech &Genome's Peter Lynch Fair Value for today is calculated as

 Peter Lynch Fair Value = PEG Ratio * 5-Year EBITDA Growth Rate * EPS without NRI (TTM) = 1 * N/A * = N/A

For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PowerShares Dynamic Biotech &Genome's EPS without NRI for the trailing twelve months (TTM) ended in . 20 was \$0.00.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate. EBITDA growth is subject to less manipulations than net earnings per share. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.

Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. The growth rate we use is the average growth rate for earnings per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA over the past 5 years, which is 0 instead of 15 in this case.

PowerShares Dynamic Biotech &Genome's Price to Peter Lynch Fair Value Ratio for today is calculated as

 Price to Peter Lynch Fair Value = Share Price / Peter Lynch Fair Value = 49.10 / N/A = N/A

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Related Terms